Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Interim analysis of the Portal extension trial evaluating the long-term safety and efficacy of the Port Delivery System with ranibizumab (PDS) in neovascular age-related macular degeneration (nAMD)

Sara Haug; Natalia Callaway; Stephanie DeGraaf; Sophie LePogam; Mel Rabena; Rob Smith; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):381 – F0212.

ARVO Annual Meeting Abstract June 2022

Archway phase 3 trial of the Port Delivery System with ranibizumab (PDS) for neovascular AMD: end-of-study results

ROBERT MITTRA; Logan Brooks; Charles Wykoff; Natalia Callaway; Stephanie DeGraaf; Anne Fung; Shamika Gune; Sophie LePogam; Robert Smith; Jeffrey Willis; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3121.

ARVO Annual Meeting Abstract June 2021

In vitro characterization of ranibizumab release from the Port Delivery System

Stefan Yohe; Katie Maass; Judit Horvath; Jennifer Rea; Giulio Barteselli; Shrirang Ranade

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):192.

ARVO Annual Meeting Abstract June 2021

The Port Delivery System with ranibizumab (PDS)—a new paradigm for long-acting retinal drug delivery

Jay M Stewart; Tammy Tam; Judit Horvath; Jennifer Rea; Giulio Barteselli; Shrirang Ranade

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):189.

ARVO Annual Meeting Abstract June 2020

Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular AMD: End of Study Results

Franco Recchia; Steven Blotner; Natasha Singh; Giulio Barteselli; Shamika Gune

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1155.

ARVO Annual Meeting Abstract June 2020

Nonclinical toxicology and biocompatibility program supporting clinical development and registration of the Port Delivery System with ranibizumab

Vladimir Bantseev; Joshua Horvath; Giulio Barteselli; Shrirang Ranade; Maia Mauricio; Daniela Bumbaca; Chris Schuetz; Amy Shelton; Helen Booler

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2966.

ARVO Annual Meeting Abstract June 2020

Optimization of the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure in the Ladder Phase 2 Trial

William R Freeman; Shamika Gune; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3703.

Perspective June 2020

Virtual Reality Becomes a Reality for Ophthalmologic Surgical Clinical Trials

PDF

Dante J. Pieramici; Felix Heimann; Raymond Brassard; Giulio Barteselli; Shrirang Ranade
TAGS: surgical procedures, operative, training, virtual reality
Trans. Vis. Sci. Tech.. 2020; 9(7):1. https://doi.org/10.1167/tvst.9.7.1

ARVO Annual Meeting Abstract July 2019

Patient experience data from the phase 2 Ladder trial of the Port Delivery System with ranibizumab

Richard F Dreyer; Melvin Rabena; Giulio Barteselli; Fan Tang; Betsy Tschosik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5388.

ARVO Annual Meeting Abstract July 2019

Port Delivery System with ranibizumab (PDS): Using Ladder phase 2 results to inform phase 3 Archway design

David Callanan; Elizabeth Morgenthien; Natasha Singh; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5192.

ARVO Annual Meeting Abstract July 2018

Post-vitrectomy ocular hemorrhage among United States adults on oral antithrombotics

Ronald A Cantrell; Jeffrey Ryuta Willis; Susanna S Park; Yifeng Chia; Mariam Abouhossein; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):883.

ARVO Annual Meeting Abstract July 2018

Development of Minipigs Surgical Model: Cauterization of the Choroid Following Scleral Dissection Mitigates Risk of Post-Operative Vitreous Hemorrhage Following Ocular Implantation of RPDS

Vladimir Bantseev; Giulio Barteselli; Chris Schuetz; Josh Horvath; Kristof Hovaten; Signe R Erickson; Jay M Stewart; Ellison Bentley; Paul E Miller; Brittney Dwyer; Jeffery J Prusakiewicz; T Michael Nork; Helen S Booler

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5929.

ARVO Annual Meeting Abstract June 2017

Spectral-Domain Optical Coherence Tomography and Optical Coherence Tomography Angiography in Sickle Cell Retinopathy

Laura Dell'Arti; Lorenzo Riva; Alessandro Invernizzi; Andrea Aretti; Giulio Barteselli; Eleonora Benatti; Claudia Mainetti; Elena Tabacchi; Francesco Viola

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1680.

ARVO Annual Meeting Abstract September 2016

Sustained Delivery of Ranibizumab: The LADDER Trial of the Ranibizumab Port Delivery System

J Jill Hopkins; Carl D Regillo; Aaron Osborne; Steven F Francom; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):530.

Retina October 2015

Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography

PDF

Jay Chhablani; Apoorva Sharma; Abhilash Goud; Hari Kumar Peguda; Harsha L. Rao; Viquar Unnisa Begum; Giulio Barteselli
TAGS: diabetes mellitus, diabetes mellitus, type 2, nerve degeneration, optical coherence tomography, eye, retinal nerve fiber layer
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6333-6338. https://doi.org/10.1167/iovs.15-17334

ARVO Annual Meeting Abstract June 2015

Correlation of vitreomacular traction with foveal thickness, subfoveal choroidal thickness and vitreomacular angle

Igor Kozak; Giulio Barteselli; Yasir Jamal Sepah; Mohammad Ali Sadiq; Robin High; Diana V Do; Quan Nguyen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1220.

Retina February 2015

Retinal Ganglion Cells Thinning in Eyes With Nonproliferative Idiopathic Macular Telangiectasia Type 2A

PDF

Jay Chhablani; Harsha B. Rao; Viquar Unnisa Begum; Ganesh Babu Jonnadulla; Ashwin Goud; Giulio Barteselli
TAGS: eye, retinal ganglion cells, telangiectasis, retinal nerve fiber layer, tissue degeneration
Invest. Ophthalmol. Vis. Sci.. 2015; 56(2):1416-1422. https://doi.org/10.1167/iovs.14-15672

ARVO Annual Meeting Abstract April 2014

Noncontact Ultra-wide field Lens system by Heidelberg Spectralis

Mark Espina; Giulio Barteselli; Feiyan Ma; Cheryl A Arcinue; Natalia Camacho; William R Freeman; Dirk-Uwe G Bartsch

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1615.

ARVO Annual Meeting Abstract April 2014

Visual Phenomenon Perceived during Vitrectomy Surgery with MAC Anesthesia

Hema Lakshmi Ramkumar; Azadeh Khatibi; Isaac Ezon; Cheryl A Arciune; Giulio Barteselli; Joseph T Nezgoda; William R Freeman; Michael Henry Goldbaum

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2207.

ARVO Annual Meeting Abstract April 2014

Choroidal Thickness changes in β-Thalassemia Syndromes using Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT)

Eleonora Benatti; Laura Dell'Arti; Giulio Barteselli; Fabio Ferrari; Chiara Mapelli; Francesco Viola; Roberto Ratiglia

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):277.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Interim analysis of the Portal extension trial evaluating the long-term safety and efficacy of the Port Delivery System with ranibizumab (PDS) in neovascular age-related macular degeneration (nAMD)

Archway phase 3 trial of the Port Delivery System with ranibizumab (PDS) for neovascular AMD: end-of-study results

In vitro characterization of ranibizumab release from the Port Delivery System

The Port Delivery System with ranibizumab (PDS)—a new paradigm for long-acting retinal drug delivery

Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular AMD: End of Study Results

Nonclinical toxicology and biocompatibility program supporting clinical development and registration of the Port Delivery System with ranibizumab

Optimization of the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure in the Ladder Phase 2 Trial

Virtual Reality Becomes a Reality for Ophthalmologic Surgical Clinical Trials

Patient experience data from the phase 2 Ladder trial of the Port Delivery System with ranibizumab

Port Delivery System with ranibizumab (PDS): Using Ladder phase 2 results to inform phase 3 Archway design

Post-vitrectomy ocular hemorrhage among United States adults on oral antithrombotics

Development of Minipigs Surgical Model: Cauterization of the Choroid Following Scleral Dissection Mitigates Risk of Post-Operative Vitreous Hemorrhage Following Ocular Implantation of RPDS

Spectral-Domain Optical Coherence Tomography and Optical Coherence Tomography Angiography in Sickle Cell Retinopathy

Sustained Delivery of Ranibizumab: The LADDER Trial of the Ranibizumab Port Delivery System

Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography

Correlation of vitreomacular traction with foveal thickness, subfoveal choroidal thickness and vitreomacular angle

Retinal Ganglion Cells Thinning in Eyes With Nonproliferative Idiopathic Macular Telangiectasia Type 2A

Noncontact Ultra-wide field Lens system by Heidelberg Spectralis

Visual Phenomenon Perceived during Vitrectomy Surgery with MAC Anesthesia

Choroidal Thickness changes in β-Thalassemia Syndromes using Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT)

To View More...

You must be signed into an individual account to use this feature.